InvestorsHub Logo
icon url

surfkast

08/08/14 1:03 PM

#17359 RE: Taylor Orion #17355

The applications of tissue regeneration in various tissue groups without the application of somatic/basal cell therapies will cost millions more. With no revenue, I believe the company will need to dilute or get more toxic financing.